Core Insights - The company Sanbai Shuo (001300) reported a total revenue of 246 million yuan for the first half of 2025, representing a year-on-year decline of 8.09% [1] - The net profit attributable to shareholders was 8.27 million yuan, down 55.28% year-on-year [1] - The second quarter revenue was 108 million yuan, a decrease of 2.0% year-on-year, with a net profit of 1.74 million yuan, down 72.21% [1] Financial Performance - The gross margin was 21.76%, a decrease of 9.57% year-on-year, while the net margin was 3.17%, down 54.05% [1] - Total sales, administrative, and financial expenses amounted to 42.32 million yuan, accounting for 17.17% of revenue, an increase of 19.39% year-on-year [1] - Earnings per share were 0.03 yuan, a decline of 55.15% year-on-year, and the net operating cash flow per share was -0.02 yuan, down 157.35% [1] Changes in Financial Items - Accounts receivable decreased by 39.36% due to the collection of overdue receivables [2] - Right-of-use assets increased by 3655.95% due to new leased factory premises [2] - Short-term borrowings rose by 632.78% as a result of increased bank loans [2] - Financial expenses increased by 80.95% due to higher exchange losses and bank fees [2] - Income tax expenses decreased by 470.05% due to a reduction in total profit [2] Cash Flow Analysis - The net increase in cash and cash equivalents rose by 119.73% due to increases in accounts payable and borrowings [3] - The net cash flow from operating activities decreased by 157.35% due to an increase in accounts payable [2] Business Evaluation - The company's return on invested capital (ROIC) was 1.28%, indicating weak capital returns, with a historical median ROIC of 19.57% since its listing [4] - The net profit margin last year was 4.04%, suggesting low added value for products or services [4] - The company has a healthy cash asset position, indicating good debt repayment capability [4] Operational Insights - The company's performance relies heavily on research and marketing efforts, necessitating a deeper investigation into the underlying drivers of these efforts [4] - The accounts receivable situation is concerning, with accounts receivable reaching 347.59% of net profit [4]

Core Viewpoint - The company, Qingdao Sanbai Shuo Health Technology Co., Ltd., has disclosed its 2025 semi-annual report and related resolutions from board meetings, indicating no changes in major shareholder structure and outlining future plans for shareholder returns and governance adjustments [1][8][14]. Company Basic Information - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6]. - The board of directors and the supervisory board have both approved the semi-annual report and its summary, with unanimous votes in favor [8][22]. Financial Data and Fund Management - The company raised a total of approximately RMB 680.74 million through its initial public offering, with a net amount of RMB 610.65 million after deducting issuance costs [50]. - As of June 30, 2025, the balance of the special account for raised funds was RMB 2.30 million, with an additional RMB 466 million in cash management accounts, totaling RMB 468.30 million [53]. - The company has utilized RMB 141.43 million of the raised funds for various projects, with plans to use up to RMB 500 million of temporarily idle funds for cash management [54][56]. Governance and Structural Changes - The company has decided to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, and has proposed amendments to its articles of association accordingly [10][23]. - A new three-year shareholder return plan for 2025-2027 has been approved, which will be submitted for shareholder meeting approval [14][26]. Upcoming Shareholder Meeting - The company plans to hold its first extraordinary general meeting of 2025 on September 9, 2025, to discuss various proposals, including the amendments to the articles of association and the shareholder return plan [18][30].

Group 1 - The company Sanbaisuo (SZ 001300) announced on August 20 that its 11th meeting of the second board of directors for 2025 was held both in person and via communication [2] - The meeting reviewed the proposal to convene the first extraordinary general meeting of shareholders in 2025 [2] - For the first half of 2025, the company's revenue composition was 100% from sports goods [2]

Group 1 - The company Sanbaisuo (SZ 001300) announced on August 20 that Mr. Fang Ruizheng has resigned from his position as the Secretary of the Board for personal reasons. After his resignation, he will not hold any position within the company [2] - For the first half of 2025, Sanbaisuo's revenue composition is entirely from sports goods, accounting for 100.0% [2]

Core Viewpoint - The company Sanbai Shuo (SZ 001300) reported a decline in both revenue and net profit for the first half of 2025 compared to the previous year [2] Financial Performance - The company's operating revenue for the first half of 2025 was approximately 246 million yuan, representing a year-on-year decrease of 8.09% [2] - The net profit attributable to shareholders was around 8.27 million yuan, reflecting a significant year-on-year decline of 55.28% [2] - Basic earnings per share were reported at 0.034 yuan, which is a decrease of 55.15% compared to the same period last year [2]

证券日报网讯8月20日晚间，三柏硕（001300）发布公告称，公司董事会于近日收到公司董事会秘书方 瑞征先生的书面辞职报告。方瑞征先生因个人原因，申请辞去公司董事会秘书职务。 ...

Group 1 - The company Sanbai Shuo (001300.SZ) reported a revenue of 246 million yuan for the first half of 2025, representing a year-on-year decrease of 8.09% [1] - The net profit attributable to shareholders of the listed company was 8.27 million yuan, down 55.28% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 4.05 million yuan, a decline of 67.09% year-on-year [1] - The basic earnings per share were 0.0340 yuan [1]

青岛三柏硕健康科技股份有限公司 投资者关系管理制度 青岛三柏硕健康科技股份有限公司 投资者关系管理制度 第一章 总则 第一条 为规范青岛三柏硕健康科技股份有限公司（以下简称"公司"）投资者关系管理 工作，加强公司与投资者之间的有效沟通，加深投资者对公司的了解和认同，促进公司与投 资者之间长期、稳定的良好关系，切实保护投资者特别是中小投资者的合法权益，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司投资者关系管理工作指引》《深圳 证券交易所股票上市规则》（以下简称《上市规则》）、《深圳证券交易所上市公司自律监管指 引第 1 号——主板上市公司规范运作》等相关法律、法规、规范性文件和《青岛三柏硕健康 科技股份有限公司章程》（以下简称"《公司章程》"）等有关规定，结合公司实际情况，制定 本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交流和诉求 处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对公司的了解和认同，以 提升公司治理水平和企业整体价值，实现尊重投资者、回报投资者、保护投资者目的的相关 活动。 第三条 公司投资者关系管理的基本原则是： （一）合规性原则 ...

青岛三柏硕健康科技股份有限公司 内幕信息知情人登记管理制度 青岛三柏硕健康科技股份有限公司 内幕信息知情人登记管理制度 第一章 总则 第一条 为加强青岛三柏硕健康科技股份有限公司（以下简称"公司"）内幕信 息管理，做好内幕信息保密工作，维护信息披露的公开、公平和公正，保护广大投资 者的合法权益，根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公 司信息披露管理办法》《上市公司监管指引第 5 号——上市公司内幕信息知情人登记 管理制度》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指 引第 1 号——主板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 5 号——信息披露事务管理》等相关法律、法规、规范性文件和《青岛三柏硕健康科技 股份有限公司章程》（以下简称《公司章程》）的规定，特制定本制度。 第二条 公司董事会是内幕信息的管理机构，应当按照本制度以及中国证券监督 管理委员会（以下简称"中国证监会"）相关规定、深圳证券交易所（以下简称"深 交所"）相关规则的要求及时登记和报送内幕信息知情人档案，并保证内幕信息知情 人档案真实、准确和完整。 第三条 董事长为公司内幕信息保密工作 ...

青岛三柏硕健康科技股份有限公司 内部审计制度 青岛三柏硕健康科技股份有限公司 内部审计制度 第一章 总则 第一条 为完善青岛三柏硕健康科技股份有限公司（以下简称"公司"）治理结构，规范 公司经济行为，提高公司内部审计工作质量，防范和控制公司风险，增强信息披露的可靠性， 保护投资者合法权益，依据《中华人民共和国公司法》《中华人民共和国证券法》《审计署关 于内部审计工作的规定》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监 管指引第 1 号——主板上市公司规范运作》等相关法律、法规、规范性文件和《青岛三柏硕 健康科技股份有限公司章程》（以下简称"《公司章程》"）等有关规定，特制定本制度。 第二条 本制度所称内部审计，是指由公司内部机构或人员对公司内部控制和风险管理 的有效性、财务信息的真实性和完整性以及经营活动的效率和效果等独立开展的一种评价活 动。目的是为了加强公司的管理和监督，防范和控制风险，改善经营管理，提高经济效益， 确保公司信息披露的真实性、准确性和完整性。 第三条 本制度所称内部控制，是指公司董事会、高级管理人员及其他有关人员为实现 下列目标而提供合理保证的过程： （一）确保公司经营管理 ...